The Latest Breaking News from EC

Check out an exclusive preview of 'A Crossroads Repetition'

The home secretary on Tuesday launched a plan to boost the UK workforce’s skills before recruiting abroad in a bid to bring overall numbers down

Hackers gained access due to poor password policy, and a lack of vulnerability patching.

The biotech industry is experiencing rapid growth owing to new drug innovations and advancements in healthcare. To capitalize on the industry's expansion, it could be wise to invest in solid biotech stocks, Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD), which have revolutionary pipelines. Read on….

The government repeated Sir Keir Starmer’s promise not to take Britain back into the single market, customs union or restore freedom of movement

The full consequences of Joe Biden’s seismic decision to withdraw from the 2024 presidential race will take some time to be felt. One immediately apparent outcome is the change of election dynamic that comes with a presumptive nominee who ticks a range of different identity boxes including gender, age and…

Everyone agrees an all-powerful AI run by one company would be a bad idea.

Lashing out at the EU, Musk claimed the bloc offered him a ‘secret deal’ to censor free speech on the social media platform

After discussions with the European Commission, Apple has agreed to open up its NFC payments system to third-party developers.

European regulators rejected PTC Therapeutics' Duchenne muscular dystrophy drug — again — sending PTC stock into free fall early Friday.

Italian PM says deal that cut out her Eurosceptic block ignored EU’s rightward shift and reflects ‘oligarchic’ mindset